FDA
-
-
-
-
-
-
-
Iterum Therapeutics secures major PBM contract covering 40 million lives
-
-
-
-
-
-
-
Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025
-
-
-
-
-
-
-
Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025
-
-
-
-
-
-
-
Iterum Therapeutics Plc (ITRM) Regains Full Nasdaq Compliance
-
-
-
-
-
-
-
FDA approves new treatment for uncomplicated urinary tract infections in adult women who have limited or no alternative oral antibiotic treatment options (ITRM)
-
-
-
-
-
-
-
Iterum Therapeutics (ITRM) PT Lowered to $5 at H.C. Wainwright
-
322,969 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

